Study fails to show benefit of adding vitamin C to treatment of septic shock
A study recently published in the Journal of the American Medial Association aimed to examine if a treatment combination of vitamin C, hydrocortisone, and…
Cardiology
Promoting safe use of parenteral anticoagulants
Parenteral anticoagulants—unfractionated and low-molecular-weight heparin—primarily are used to prevent and treat VTE (deep vein thrombosis [DVT] and pulmonary embolism [PE]) associated with medical conditions…
Cardiogenic pulmonary edema
Albert Jones*, age 65, is admitted to the progressive care unit from the emergency department when he tests positive for sepsis, secondary to a…
A team approach to STEMI treatment protocols
MOST current ST-elevation myocardial infarction (STEMI) practice guidelines focus on recommendations for patients who present to the emergency department (ED), leaving in-hospital STEMIs overlooked.…
Managing carotid stenosis to prevent stroke
According to the AHA, stroke, which can be classified as ischemic (blood flow to the brain is blocked) or hemorrhagic (bleeding occurswithin or around…
Study reveals no link between statin use and cognitive decline
A new study offers insight into a question that’s plagued healthcare for some time: Does an association exist between statin use and cognitive decline?…
New research in the prevention of venous thromboembolism
A recent study examines the use of intermittent pneumatic compression (IPC) to prevent venous thromboembolism (VTE) in patients who are at high-risk for the…
Central vascular access device complications:
APPROXIMATELY 5 million central vascular access devices (CVADs) are inserted into U.S. patients every year, and at least 85% of hospitalized patients receive some…
Atypical presentation of myocardial infarction
Cardiovascular disease remains the leading cause of death in women, but it’s often under-recognized because of atypical symptoms. Women may experience vague symptoms that…
Acute cardiogenic pulmonary edema
RONALD BARRETT* is admitted to the medical telemetry unit after arriving in the ED after 2 days of nocturnal dyspnea and mild chest pressure.…
FDA approves treatment for two rare diseases
On May 6, the FDA approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome in patients 6 to less than 17 years…
Myths of I.V. push administration
Learn the truth about safe administration. Many myths abound about I.V. push medications. To dispel these myths and outline evidence-based standards of practice, American…
Study fails to show benefit of adding vitamin C to treatment of septic shock
A study recently published in the Journal of the American Medial Association aimed to examine if a treatment combination of vitamin C,…
Promoting safe use of parenteral anticoagulants
Parenteral anticoagulants—unfractionated and low-molecular-weight heparin—primarily are used to prevent and treat VTE (deep vein thrombosis [DVT] and pulmonary embolism [PE]) associated with…
Cardiogenic pulmonary edema
Albert Jones*, age 65, is admitted to the progressive care unit from the emergency department when he tests positive for sepsis, secondary…
A team approach to STEMI treatment protocols
MOST current ST-elevation myocardial infarction (STEMI) practice guidelines focus on recommendations for patients who present to the emergency department (ED), leaving in-hospital…
Managing carotid stenosis to prevent stroke
According to the AHA, stroke, which can be classified as ischemic (blood flow to the brain is blocked) or hemorrhagic (bleeding occurswithin…
Study reveals no link between statin use and cognitive decline
A new study offers insight into a question that’s plagued healthcare for some time: Does an association exist between statin use and…
New research in the prevention of venous thromboembolism
A recent study examines the use of intermittent pneumatic compression (IPC) to prevent venous thromboembolism (VTE) in patients who are at high-risk…
Central vascular access device complications:
APPROXIMATELY 5 million central vascular access devices (CVADs) are inserted into U.S. patients every year, and at least 85% of hospitalized patients…
Atypical presentation of myocardial infarction
Cardiovascular disease remains the leading cause of death in women, but it’s often under-recognized because of atypical symptoms. Women may experience vague…
Acute cardiogenic pulmonary edema
RONALD BARRETT* is admitted to the medical telemetry unit after arriving in the ED after 2 days of nocturnal dyspnea and mild…
FDA approves treatment for two rare diseases
On May 6, the FDA approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome in patients 6 to less than…
Myths of I.V. push administration
Learn the truth about safe administration. Many myths abound about I.V. push medications. To dispel these myths and outline evidence-based standards of…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.